This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Seaside Therapeutics, Inc., Laboratory Corporation of America Holdings, Massachusetts Institute of Technology. Active years: 2012-2020.
Company Filing History:
3 out of 3 
2 out of 126 
2 out of 8,573 
Years Active: 2012-2020
Title: **Mark Firman Bear: Pioneer in Autism and Fragile X Syndrome Research**
Introduction
Mark Firman Bear is a renowned inventor based in Boston, MA, known for his significant contributions to the field of neuroscience and genetic disorders. With a total of seven patents to his name, Bear's work primarily focuses on innovative methodologies for treating and diagnosing complex conditions such as fragile X syndrome and autism spectrum disorders.
Latest Patents
Among Bear's latest innovations are groundbreaking patents that aim to enhance the understanding and treatment of fragile X syndrome. One of his notable patents discusses methods of treating fragile X syndrome and related disorders. This invention proposes novel methodologies to inhibit mGlu-relevant signaling pathways by reducing β-arrestin2 protein levels or diminishing the interactions between mGlu and β-arrestin2 proteins.
In addition to his work on fragile X syndrome, Bear has also developed methods for diagnosing autism spectrum disorders. This invention generally relates to techniques for diagnosing the presence or increased risk of developing an autism spectrum disorder in a subject, potentially impacting countless individuals and their families.
Career Highlights
Throughout his career, Mark Firman Bear has worked with several esteemed organizations, including Seaside Therapeutics, Inc., and Laboratory Corporation of America Holdings. His contributions in these roles have helped shape the landscape of research in autism and fragile X syndrome, making significant strides in understanding these disorders.
Collaborations
Bear has collaborated with several notable professionals in his field, including Kathryn Roberts and Randall L Carpenter. These collaborations have fostered an environment of innovation and research excellence, further advancing the scientific community's progress in addressing critical issues related to fragile X syndrome and autism.
Conclusion
Mark Firman Bear continues to be an influential inventor in the field of neuroscience, making significant contributions through his patents and collaborative efforts. His work not only highlights the importance of innovation in medicine but also offers hope for those affected by fragile X syndrome and autism spectrum disorders. As the research community evolves, Bear's ongoing efforts will undoubtedly pave the way for new advancements in treatment and diagnosis.